Douglas Hanlon
- Immunology top 5%
- Immunotherapy and Immune Responses 27
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 8
- Dermatology top 2%
- Cutaneous lymphoproliferative disorders research 8
- Pharmaceutical Science top 5%
- Cell Biology top 10%
- Oncology top 10%
- CAR-T cell therapy research 13
-
- RNA Interference and Gene Delivery 7
-
- SARS-CoV-2 detection and testing 2
-
- Photodynamic Therapy Research Studies 2
- Co-authors
- Richard L. EdelsonVirginia CodyW. Mark SaltzmanCarole L. BergerHong ShenPeter CresswellAnne L. AckermanAlessandra Giodini
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Douglas Hanlon
37 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Immunology 894
- Dermatology 291
- Pharmaceutical Science 85
- Cell Biology 213
- Oncology 318
Countries citing papers authored by Douglas Hanlon
This map shows the geographic impact of Douglas Hanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Hanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Hanlon more than expected).
Fields of papers citing papers by Douglas Hanlon
This network shows the impact of papers produced by Douglas Hanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Hanlon. The network helps show where Douglas Hanlon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas Hanlon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 11 | |
| 2 | 2020 | 53 | |
| 3 | 2019 | 1 | |
| 4 | 2019 | 6 | |
| 5 | 2018 | 44 | |
| 6 | 2015 | 21 | |
| 7 | 2015 | 26 | |
| 8 | 2012 | 21 | |
| 9 | 2011 | 41 | |
| 10 | 2011 | 22 | |
| 11 | 2010 | 86 | |
| 12 | 2007 | 80 | |
| 13 | 2005 | 324 | |
| 14 | 2004 | 13 | |
| 15 | 2002 | 53 | |
| 16 | 1998 | 1 | |
| 17 | 1998 | 34 | |
| 18 | 1997 | 30 | |
| 19 | 1997 | 1 | |
| 20 | 1989 | 2 |
About Douglas Hanlon
Douglas Hanlon is a scholar working on Immunology, Dermatology and Oncology, having authored 38 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (27 papers), CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (9 papers), Cutaneous lymphoproliferative disorders research (8 papers), T-cell and B-cell Immunology (8 papers), RNA Interference and Gene Delivery (7 papers), SARS-CoV-2 detection and testing (2 papers) and Photodynamic Therapy Research Studies (2 papers). The work is most often cited by research in Immunology (894 citations), Dermatology (291 citations) and Pharmaceutical Science (85 citations). Douglas Hanlon has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Richard L. Edelson, Virginia Cody, W. Mark Saltzman, Carole L. Berger, Hong Shen, Peter Cresswell, Anne L. Ackerman, Alessandra Giodini, Ella R. Hinson and Jennifer K. Saucier-Sawyer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.